Glutaryl-CoA dehydrogenase deficiency : a study showed that newborn screening programs for Glutaric aciduria type 1 have an overall positive effect on the neurological outcome but their success depends on the quality of therapy Consult the pubmed abstract To read more about “Glutaryl-CoA dehydrogenase deficiency” Genet Med . 2021 Jan;23(1):13-21. (source: OrphaNews 10 May 2021) Related news Report NGO Committee for Rare Diseases on Rare Disease Day event “Rare Diseases: A Global Priority for Equity” The NGO Committee for Rare Diseases and its partners, including Rare D... Campaign for the adoption of a Rare Disease strategy in Canada The Canadian Organization for Rare Disorders (CORD) has launched a cam... Launch of the European Health Data Space On 3 May 2022, the European Commission has launched the European Healt... Mothers’ knowledge and attitudes about newborn screening in Jordan A new article has been published in the Journal of Community Genetics ... MetabERN: Article on the Screen4rare initiative for newborn screening programmes in Europe MetabERN has published a new article in the Lancet Regional Health jou... MetabERN: Study on the evolution of rare disease registries MetabERN has published a new article in the Frontiers in Endocrinology...